[Study on recombinant hepatitis B vaccine: development of ELISA methods for detection of contaminating yeast components in the vaccine and humoral anti-yeast component antibody developed in humans and guinea-pigs].
Ohtani
W
W
Ohmizu
A
A
Sumi
A
A
Ohmura
T
T
Uemura
Y
Y
Yokoyama
K
K
D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis*; D004340:Drug Contamination; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006168:Guinea Pigs; D006510:Hepatitis B Antibodies / Q000032:analysis; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006801:Humans; D008297:Male; D011995:Recombination, Genetic; D012441:Saccharomyces cerevisiae / Q000276:immunology*; D014761:Viral Hepatitis Vaccines / Q000032:analysis*
D000907:Antibodies, Bacterial; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D014761:Viral Hepatitis Vaccines